Why I’m excited to bring the Applied Biophysics Forum in Drug Delivery to the US

When I attended the Applied Biophysics Forum earlier this year in Mainz, Germany, what struck me most wasn’t just the quality of the science—it was also the openness and collaboration among everyone.

Whether it was during the keynote talks or standing around a poster over coffee, the conversations were grounded in the day-to-day challenges of developing lipid nanoparticle (LNP) therapeutics. I found myself in conversations with academics, colleagues from big pharma and small biotech start-ups and representatives from regulatory bodies. What’s more, there was a great balance (around 50/50) of people coming from academia and industry – which is something you see at most conferences.

That’s why I’m so excited that we’re now launching the first-ever US edition of the Applied Biophysics Forum in Drug Delivery this September 10–11 in Cambridge, MA.

A forum rooted in collaboration

What started as a gathering of 50 scientists in Stockholm in 2023, has since doubled in size and become a much-anticipated annual event for attendees. It’s still small enough for meaningful interaction with every attendee, yet large enough to bring a diversity of perspectives to the table.

Thanks to the open and collaborative nature of the event, the Applied Biophysics Forum in Drug Delivery has become a platform for real scientific exchange in Europe.

What makes this event special?

There are a lot of events in the pharma and biotech space. But what sets this one apart is the shared understanding that without robust biophysical characterization tools, we don’t truly know what we’re working with.

During this two-day interactive workshop, we’ll explore how tools like DSC, DLS, SAXS and NTA support the development of nucleic acid therapeutics like mRNA, siRNA, and CAR T-cell therapies. We’ll answer questions like:

• What can we learn from industry leaders like Sanofi and Mote Therapeutics?
• How can we build scalable workflows that support innovation without compromising quality?
• What are the breakthroughs from academic research and how that can apply to the development of LNP platforms.

Call for posters: share your research

One of my favorite parts of the Mainz meeting was the poster session. Every attendee was invited to share their research – whether it was published, in progress. And that’s exactly what we’re doing again in Cambridge.

So, if you’re working on anything from LNP formulation or lyophilization to analytical methods or regulatory affairs, we want to hear from you. Register now. Submit a poster. Join the conversation. Let’s move the science forward—together.

Join us in Cambridge

It’s no coincidence that we chose Cambridge, MA to host this event – it’s a global hub for biotech innovations, so the location should prove reasonably local to the people that will benefit most from attending. Whether you’re in academia, biotech, big pharma, or a regulatory role, I hope you’ll join us.

📅 September 10–11, 2025
📍 Cambridge, MA
🔗https://events.malvernpanalytical.com/Applied-Biophysics-US-250910

Networking and interaction are a key part of this event, so we are deliberately starting small. Our venue accommodates 50 and places are filling up fast.